Hany Massarany - May 20, 2021 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Director
Signature
/s/ Steven Reichling, attorney-in-fact
Stock symbol
AXDX
Transactions as of
May 20, 2021
Transactions value $
$0
Form type
4
Date filed
5/24/2021, 09:59 PM
Next filing
Jul 1, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Stock Option (right to buy) Award $0 +93.8K $0.00 93.8K May 20, 2021 Common Stock 93.8K $7.68 Direct F1
transaction AXDX Stock Option (right to buy) Award $0 +31.3K $0.00 31.3K May 20, 2021 Common Stock 31.3K $7.68 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in five equal annual installments beginning on May 20, 2022.
F2 The option vests in full on May 20, 2022.